GGrantIndex
← Leaderboards

Adriana Weinberg

University Of Colorado Denver

Google Scholar ↗PubMed ↗ORCID ↗
$9,708,858
Attributed
$13,616,546
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,616,546 · 15

By mechanism

U01$7,195,340 · 2
R01$4,941,367 · 4
R21$1,290,873 · 3
M01$188,966 · 6

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Immune Response”

Research focus

Immune ResponseImmuneInfectionResponsePeripheral Blood Mononuclear CellCharacteristicsEpigenetic ProcessVaccinesT-LymphocyteCellsImmunityPhenotypePlasmaImmunologicsAdultMorbidity - Disease RateInfantMediatingAntigen-Presenting CellsCessation Of LifeUmbilical Cord BloodCellular ImmunityRegulatory T-LymphocyteHiv-Exposed Uninfected Infant

Grant awards (37)

PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION$765,085
U01 · FY2025 · AI · contact PI
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$761,784
R01 · FY2025 · HD · contact PI
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$17,647
R01 · FY2025 · HD · contact PI
PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION$704,735
U01 · FY2024 · AI · contact PI
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$688,425
R01 · FY2024 · HD · contact PI
Relationship between maternal and fetal immune responses$477,720
R01 · FY2024 · HD · contact PI
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS$685,272
U01 · FY2023 · AI · contact PI
Relationship between maternal and fetal immune responses$480,211
R01 · FY2023 · HD · contact PI
DYNAMICS OF M. TUBERCULOSIS-SPECIFIC INNATE AND ADAPTIVE IMMUNITY DURING PREGNANCY AND POSTPARTUM IN WOMEN WITH HIV$198,803
R21 · FY2023 · AI · contact PI
EFFECT OF NEONATAL BCG ADMINISTRATION ON INNATE AND ADAPTIVE IMMUNE RESPONSES TO INFECTION WITH ROTAVIRUS LIVE ATTENUATED VACCINE STRAIN IN HIV-EXPOSED AND UNEXPOSED INFANTS$155,500
R01 · FY2023 · HD · contact PI
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS$699,825
U01 · FY2022 · AI · contact PI
Relationship between maternal and fetal immune responses$494,084
R01 · FY2022 · HD · contact PI
INFLUENZA-SPECIFIC IMMUNITY AND RESPONSES TO INACTIVATED INFLUENZA VACCINE IN INFANTS: EFFECT OF MATERNAL VACCINATION DURING PREGNANCY$466,498
R01 · FY2022 · AI · contact PI
DYNAMICS OF M. TUBERCULOSIS-SPECIFIC INNATE AND ADAPTIVE IMMUNITY DURING PREGNANCY AND POSTPARTUM IN WOMEN WITH HIV$243,843
R21 · FY2022 · AI · contact PI
EFFECT OF NEONATAL BCG ADMINISTRATION ON INNATE AND ADAPTIVE IMMUNE RESPONSES TO INFECTION WITH ROTAVIRUS LIVE ATTENUATED VACCINE STRAIN IN HIV-EXPOSED AND UNEXPOSED INFANTS$155,500
R01 · FY2022 · HD · contact PI
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS$704,995
U01 · FY2021 · AI · contact PI
INFLUENZA-SPECIFIC IMMUNITY AND RESPONSES TO INACTIVATED INFLUENZA VACCINE IN INFANTS: EFFECT OF MATERNAL VACCINATION DURING PREGNANCY$466,498
R01 · FY2021 · AI · contact PI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$455,979
U01 · FY2021 · AI · contact PI
EFFECT OF NEONATAL BCG ADMINISTRATION ON INNATE AND ADAPTIVE IMMUNE RESPONSES TO INFECTION WITH ROTAVIRUS LIVE ATTENUATED VACCINE STRAIN IN HIV-EXPOSED AND UNEXPOSED INFANTS$155,500
R01 · FY2021 · HD · contact PI
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS$715,495
U01 · FY2020 · AI · contact PI
INFLUENZA-SPECIFIC IMMUNITY AND RESPONSES TO INACTIVATED INFLUENZA VACCINE IN INFANTS: EFFECT OF MATERNAL VACCINATION DURING PREGNANCY$466,500
R01 · FY2020 · AI · contact PI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$456,248
U01 · FY2020 · AI · contact PI
EFFECT OF NEONATAL BCG ADMINISTRATION ON INNATE AND ADAPTIVE IMMUNE RESPONSES TO INFECTION WITH ROTAVIRUS LIVE ATTENUATED VACCINE STRAIN IN HIV-EXPOSED AND UNEXPOSED INFANTS$155,500
R01 · FY2020 · HD · contact PI
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS$729,245
U01 · FY2019 · AI · contact PI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$449,834
U01 · FY2019 · AI · contact PI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$409,739
U01 · FY2018 · AI · contact PI
The role of innate immunity in the acquisition of sterile protection against TB infection$186,139
R21 · FY2018 · AI · contact PI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$418,888
U01 · FY2017 · AI · contact PI
The role of innate immunity in the acquisition of sterile protection against TB infection$222,072
R21 · FY2017 · AI · contact PI
Reconstitution of Protective CMV Immunity and Immune Regulation After HAART$231,516
R21 · FY2008 · AI · contact PI
Reconstitution of Protective CMV Immunity and Immune Regulation After HAART$208,500
R21 · FY2007 · AI · contact PI
SERUM BILE ACID LEVEL IN PREGNANT WOMEN WITH AND WITHOUT HIV INFECTION$124,636
M01 · FY2007 · RR · contact PI
IMMUNOLOGIC EVALUATIONS OF HIV-INFECTED PREGNANT WOMEN ON HAART$31,246
M01 · FY2007 · RR · contact PI
SERUM BILE ACID LEVEL IN PREGNANT WOMEN WITH AND WITHOUT HIV INFECTION$17,908
M01 · FY2006 · RR · contact PI
IMMUNOLOGIC EVALUATIONS OF HIV-INFECTED PREGNANT WOMEN ON HAART$8,528
M01 · FY2006 · RR · contact PI
ACTG A5084: ANTIRETROVIRAL MEDICATIONS IN HIV-1 INFECTED PREGNANT WOMEN$6,099
M01 · FY2005 · RR
SERUM BILE ACID LEVEL IN PREGNANT WOMEN WITH AND WITHOUT HIV INFECTION$549
M01 · FY2005 · RR